Acute ischemic stroke
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Continuous inclusion of stroke greenway patients who visited our hospital from June 1, 2024 to December 31, 2025. Inclusion criteria: (1) Age >=18 years old; (2) Acute ischemic stroke; (3) Plan to undergo intravenous thrombolysis, bridging endovascular treatment, or direct endovascular treatment; (4) The patient or their legal representative signs an informed consent form.
Exclusion criteria
Exclusion criteria: Exclusion criteria: (1) Head CT indicates intracranial hemorrhagic disease; (2) Direct intravascular treatment reveals thrombotic autolysis, only cerebral angiography is performed; (3) Individuals with coagulation disorders, thrombocytopenia, a history of systemic hemorrhage, or severe liver and kidney diseases, with absolute contraindications for intravenous thrombolysis or endovascular treatment; (4) Having serious cardiovascular and pulmonary diseases, the researchers believe that it is not suitable to participate in this study; (5) Patients with an expected lifespan of less than 3 months or unable to complete the study due to other reasons; (6) Pregnant or lactating women; (7) Individuals who are unable to complete this study due to mental illness, cognitive or emotional disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 90 day modified Rankin score; | — |
Secondary
| Measure | Time frame |
|---|---|
| door to needle time;24-hour vascular recanalization rate (including thrombolysis and thrombectomy);Data omission rate;Remedial endovascular treatment rate;Early neurological deterioration rate (24-hour NIHSS score = 4 points compared to pre-treatment);36 hour incidence of symptomatic intracranial hemorrhage;90 day all-cause mortality rate;Adverse events and serious adverse events; | — |
Countries
China
Contacts
Beijing Daxing District People's Hospital